75
Participants
Start Date
August 7, 2023
Primary Completion Date
December 31, 2024
Study Completion Date
July 31, 2025
2mg CS0159
Oral QD
Placebo
Oral QD
Beijing Friendship Hospital, Captail Medcial University, Beijing
Beijing Youan Hostital, Captial Medical University, Beijing
Peking Union Medical College Hospital, Beijing
Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai
The First Affiliated Hospital of USTC Anhui Provincial Hospital, Hefei
Shaoyifu Hospital of Zhejiang University Medical, Hangzhou
The Seconed Xiangya Hospital of Central South University, Changsha
Wuhan Union Hospital of China, Wuhan
The Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou
The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou
Henan Provincial People's Hospital, Zhengzhou
The Third People's Hospital of Zhenjiang, Zhenjiang
The First Bethune Hospital of Jilin University, Changchun
Qilu Hospital of Shandong University, Jinan
West China Hospital, Sichuan University, Chengdu
The First Affiliated Hospital,Zhejiang University School of Medicine, Hangzhou
Lead Sponsor
Cascade Pharmaceuticals, Inc
OTHER